The City has been dealt a “symbolic blow” after the latest data revealed that Amsterdam eclipsed London as Europe’s largest share-trading centre in January, says Kalyeena Makortoff in The Guardian. Amsterdam, “previously the sixth-largest exchange centre in Europe”, saw average daily trading surge from €2.6bn to €9.2bn in January as exchanges “shifted order books abroad after Brexit”. London is now in second place, “with average daily trading halving from €17.5bn to €8.6bn last month”, according to the Chicago Board Options Exchange.
The figures aren’t as bad as they look for the LSE Group (which owns the London Stock Exchange), says Jill Treanor in The Sunday Times. After all, much of the additional volume hasn’t gone to Amsterdam’s main exchange, but to the Turquoise platform, which is part owned by the LSE Group. Still, there are signs that “more business is moving”, with London’s share of euro-denominated swap activity falling from “40% in July to 10% last month”. The lost business is going to the US as well as the EU.
The problem could get worse if the EU continues to play “hardball” with the UK on access to its financial markets, say Peter Thal Larsen and Dasha Afanasieva on Breakingviews. When the transitional arrangements between Britain and the EU expired at the end of the year, Brussels declined to grant the United Kingdom approval as an “equivalent” country in most areas, including those related to trading shares and interest-rate swaps. Even where it did grant equivalence, it also signalled that it expects EU investors and companies to reduce their exposure to UK counterparties over time, which could reduce trading volumes further. Given the pressure London is under, it’s no surprise that the LSE Group is pressing the government to “move quickly” to “overhaul the UK’s listing rules”, says Philip Stafford in the Financial Times. CEO David Schwimmer wants the government to relax the rules that require start-ups “to sell a minimum of 25% of their company” when they go public. Schwimmer argues that this requirement is a “deterrent to potential IPO [initial public offering] candidates”. The purchase of data provider Refinitiv, completed last month, should also help diversify LSE Group’s sales.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Too soon to panic
It is important to remember, that London “is not just captured in the LSE”, says Gerard Lyons in The Spectator. After all, not only does the “vast bulk” of trading take place outside the public markets (banks and other financial institutions match up trades internally), but even when trades are technically booked in Amsterdam “the value in the trade for an economy remains in London”, thanks to “activities such as settlement, clearing and risk management”. The City also benefits from “Brexit-proof” competitive advantages, including “English common law, time-zone, language, flexible workforce” and the “skills, knowledge and experience based here”.
-
Investors pull money from UK equities as government warns of “painful” BudgetThe government’s post-election honeymoon period has been short-lived, and investors are shying away from UK equities as a result
-
Top global fintech companies to invest inOne British fintech hogs the headlines, but there are two top performers in the US. We explain where you should put your money
-
Qualcomm could acquire rival Intel – but securing the deal won't be easyA tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
-
Modi’s reforms set Indian stocks on fireIndian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
-
How to invest in the quiet market monthsHere's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
-
Spire Healthcare: invest in the booming demand for private healthcareSpire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
-
Are insurance companies a good investment?Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
-
Dr Martens shares slump: should you give it the boot?Over the past three years, Dr Martens has fallen out of fashion. Are the shares worth a look?
-
Google's legal challenges – could it be broken up?Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
-
Fast-growing bargain stocks the market has missedA professional investor recommends attractive stocks to invest in. This week: Dan Higgins, portfolio manager, Majedie Investments, highlights three favourites
